Oramed to Present at the GTC Diabetes Summit
PR Newswire - Mon Apr 20, 7:15AM CDT
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the company will participate in the upcoming Annual GTC Diabetes Summit, in the 8th Diabetes Drug Discovery & Development Conference, taking place April 27-29, 2015 in Boston. Dr. Miriam Kidron, Oramed's Chief Scientific Officer, will present a session titled "Early Clinical Impressions of Oral Insulin in Type 1 Diabetes Patients" on April 28, 2015.
ORMP: 7.25 (-0.10)
Nasdaq stocks posting largest volume increases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NSYS: 4.79 (-0.14), DOVR: 8.42 (-0.02), EBIO: 10.32 (+0.22), ORMP: 7.25 (-0.10), AHPI: 1.53 (-0.04), SYRX: 2.09 (-0.05), INPH: 1.39 (-0.10), AXPW: 0.04 (unch), NTIC: 17.51 (+0.71), THTI: 0.97 (-0.02)
Nasdaq stocks posting largest percentage increases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
HTBX: 7.71 (-0.64), DOVR: 8.42 (-0.02), STCK: 18.52 (-0.02), CLVS: 85.04 (-1.36), ORMP: 7.25 (-0.10), BIND: 7.01 (-0.30), EGRX: 60.53 (+1.22), VLTC: 15.14 (-1.04), BCLI: 4.29 (-0.09), REPH: 10.71 (-0.78)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 11:44AM CDT
NPD: 2.87 (+0.25), TEAR: 2.39 (+0.08), UQM: 1.02 (-0.02), ASPS: 18.07 (+1.32), CPHR: 11.34 (+0.44), SYRX: 2.09 (-0.05), CHOP: 3.67 (-0.26), NTLS: 5.46 (+0.17), HKTV: 7.67 (-0.33), PME: 1.88 (-0.12), CALI: 1.38 (+0.01), GBSN: 4.98 (+1.44), CTSO: 7.13 (-0.06), ORMP: 7.25 (-0.10), CYTX: 0.96 (-0.09), EXA: 11.49 (+0.01), BAS: 7.88 (+0.07), ENRJ: 1.75 (+0.05), BLDR: 13.00 (-0.09), REPH: 10.71 (-0.78)
Oramed up on bullish outlooks
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 9:36AM CDT
ORMP: 7.25 (-0.10)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 8:15AM CDT
FRO: 2.77 (-0.20), GBSN: 4.98 (+1.44), P: 17.51 (+0.28), CLVS: 85.04 (-1.36), ARWR: 6.88 (+0.14), ORMP: 7.25 (-0.10), BLDR: 13.00 (-0.09), IFON: 2.73 (+0.13)
Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin
PR Newswire - Wed Apr 01, 9:06AM CDT
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the first patient has been enrolled in its Glucose Clamp Study. The study will be performed at The University of Texas Health Science Center at San Antonio and University Health System's Texas Diabetes Institute under the supervision of Professor Ralph DeFronzo.
ORMP: 7.25 (-0.10)
Market Maker Surveillance Report. NEON, RCON, SGNL, ORMP, FNJN, DPLO, Winning Stocks With Lowest Price Friction For Tuesday, March 24th 2015
M2 - Wed Mar 25, 3:25AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5602 companies with "abnormal" market making, 2685 companies with positive Friction Factors and 3096 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Neonode Inc (NASDAQ:NEON), Recon Technology Ltd (NASDAQ:RCON), SIGNAL-HILL CORP (NASDAQ:SGNL), Oramed Pharmaceuticals Inc (NASDAQ:ORMP), (NASDAQ:FNJN), (NYSE
SGNL: 2.21 (+0.02), NEON: 4.45 (+0.23), DPLO: 34.52 (+0.26), ORMP: 7.25 (-0.10), FNJN: 1.46 (-0.10), RCON: 1.87 (-0.04)